Valens Semiconductor Outlines Long-Term Growth and Value Creation Strategy at 2024 Investor Day
Expands leading-edge connectivity solutions in high-growth industriesAnnounces long-term financial goals HOD HASHARON, Israel, Nov. 12, 2024 /PRNewswire/ —... Read more.
MATSON TO PARTICIPATE AT STEPHENS 2024 ANNUAL INVESTMENT CONFERENCE
HONOLULU, Nov. 12, 2024 /PRNewswire/ — Matson, Inc. (NYSE: MATX) announced today that Joel Wine, Executive Vice President and Chief Financial Officer, will... Read more.
SurgePays Announces Third Quarter 2024 Financial Results
Migration of former ACP Subscribers to Lifeline Well Underway BARTLETT, Tenn., Nov. 12, 2024 /PRNewswire/ — SurgePays, Inc. (Nasdaq: SURG) (“SurgePays”... Read more.
Audiokinetic’s Wwise Automotive enables a new standard for immersive in-car audio in CHANGAN’s new NEVO E07 electric vehicle
SHANGHAI, Nov. 13, 2024 /PRNewswire/ – Audiokinetic Inc., the leading provider of cross-platform interactive audio solutions, is proud to announce its contribution... Read more.
Decode economic ties between GBA and Colombia from a cup of coffee
GUANGZHOU, China, Nov. 4, 2024 /PRNewswire/ — News report from GDToday. The Guangdong-Hong Kong-Macao Greater Bay Area (GBA), one of China’s most open... Read more.
Stay Better in China: Tell the Beautiful China to the World
NANCHANG, China, Nov. 9, 2024 /PRNewswire/ — A report from Jiangxi International Communication Center (JXICC): Komurcu Busra, an international student from... Read more.
LG Display Succeeds in Developing World’s First Stretchable Display that Expands by 50 Percent
SEOUL, South Korea , Nov. 9, 2024 /PRNewswire/ — LG Display, the world’s leading innovator of display technologies, announced today its unveiling of... Read more.
CloudOne Digital Appoints Packet Cofounder and Former Equinix Executive Zach Smith to Board of Directors to Drive Growth in Bare Metal and Hybrid-Cloud Solutions
ATLANTA, Nov. 9, 2024 /PRNewswire/ — CloudOne Digital, a leader in cloud-based infrastructure solutions, proudly announces the appointment of Zachary Smith... Read more.
Marengo Presents Promising First-in-Human Safety, Tolerability and Clinical Activity Data for its Lead Program, Invikafusp Alfa (STAR0602), at the 2024 SITC Annual Meeting
STARt-001 is the first clinical study to evaluate Marengo’s novel, selective Vβ TCR agonist technology to promote in vivo expansion and reprogramming of tumor-infiltrating... Read more.
Sapience Therapeutics Presents Clinical Data on Two Lead Programs, Including ST101 Oral Presentation, at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
-ST101 Phase 2 data demonstrates activation of the tumor immune microenvironment in glioblastoma (GBM)– -ST316 Phase 1 data demonstrates antagonism of β-catenin-driven... Read more.